Implication of polygenic risk on platelet reactivity in patients with acute coronary syndrome treated with clopidogrel.
Grant
Overview
Affiliation
Research
View All
Overview
abstract
To determine the involvement of polygenic risk in platelet reactivity in patients with acute coronary syndrome treated with clopidogrel at the Hospital Universitario Mayor-Méderi.